Company Filing History:
25 out of 451 
2 out of 1,974 
1 out of 3,222 
Years Active: 1996-2016
Title: Innovations of Stewart D. Lyman: Pioneering Advances in Immunology
Introduction
Stewart D. Lyman, based in Seattle, WA, is a prominent inventor in the field of immunology, holding an impressive portfolio of 28 patents. His innovative contributions significantly advance our understanding and treatment of immune system disorders, particularly through the development of novel therapies targeting thymic stromal lymphopoietin (TSLP).
Latest Patents
Among his latest patents, Stewart has developed antibodies that inhibit TSLP activity. This invention includes purified and isolated novel TSLP polypeptides, the nucleic acids encoding such polypeptides, and processes for producing recombinant forms of these polypeptides. Additionally, it encompasses antibodies generated against these polypeptides, fragmented peptides derived from them, and various uses of the aforementioned inventions. Another notable patent involves nucleic acids encoding modified human TSLP polypeptides. This invention presents modified, furin-resistant human TSLP polypeptides and the corresponding polynucleotides, along with pharmaceutical compositions, B and T cell activation agents, assays, and methods of use.
Career Highlights
Stewart D. Lyman has made substantial contributions to the field while working in esteemed companies such as Immunex Corporation and Amgen Inc. His roles at these institutions have facilitated the translation of scientific research into therapeutic applications, enhancing patient outcomes in immunological treatments.
Collaborations
Throughout his career, Stewart has had the opportunity to collaborate with notable professionals in the field, including M. Patricia Beckmann and John Ernest Sims. These collaborations have fostered innovative research endeavors, allowing for interdisciplinary approaches to the challenges faced in immunology.
Conclusion
Stewart D. Lyman continues to be a leader in immunology innovation, with a robust portfolio of patents that reflect his commitment to advancing medical science. His work exemplifies the critical role of inventors in developing new therapies that enhance our understanding of the immune system and improve health outcomes for patients.